Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

27.67
+0.99003.71%
Post-market: 27.880.2100+0.76%19:58 EDT
Volume:5.03M
Turnover:138.63M
Market Cap:4.42B
PE:-67.27
High:28.72
Open:27.09
Low:27.03
Close:26.68
52wk High:28.72
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:2.71
T/O Rate:4.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:30.93
PE(LYR):-70.56

Loading ...

Adaptive Biotechnologies Corp : TD Cowen Cuts Target Price to $19 From $21

THOMSON REUTERS
·
Apr 14

Adaptive Biotechnologies President and COO Julie Rubinstein sells USD 526,477 shares

Reuters
·
Apr 14

Adaptive Biotechnologies Chief People Officer Francis Lo sells $340,043 common shares

Reuters
·
Apr 11

Adaptive Biotech CSO Harlan Robins sells 10,000 shares worth $148,500

Reuters
·
Apr 11

Adaptive Biotechnologies CEO Chad Robins disposes of USD 1.8 million common shares

Reuters
·
Apr 09

Adaptive Biotechnologies President, COO Julie Rubinstein disposes of USD 983,470 shares

Reuters
·
Apr 09

Adaptive Biotechnologies (ADPT) Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals

Simply Wall St.
·
Apr 06

Adaptive Biotechnologies President, COO Julie Rubinstein disposes common shares worth 0.6 million

Reuters
·
Apr 03

Adaptive Biotechnologies President and COO Julie Rubinstein; disposes of common shares worth $796,516

Reuters
·
Mar 27

Adaptive Biotechnologies launches clonoSEQ MRD test for blood cancers

Reuters
·
Mar 25

Adaptive Biotechnologies President and COO Julie Rubinstein disposes of USD 765,393 in common shares

Reuters
·
Mar 24

Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Q4 Results And MRD Growth

Simply Wall St.
·
Mar 20

Adaptive Biotechnologies President and COO Julie Rubinstein reports USD 766,000 common share disposal

Reuters
·
Mar 19

Adaptive Biotechnologies (ADPT) Is Down 11.9% After MRD-Led Earnings Beat And Tax-Driven Insider Sales - Has The Bull Case Changed?

Simply Wall St.
·
Mar 17

Adaptive Biotechnologies Chief People Officer Francis Lo Disposes of Common Shares

Reuters
·
Mar 14

Adaptive Biotechnologies Director Michelle Renee Griffin Disposes of Common Shares

Reuters
·
Mar 06

Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins Disposes of Common Shares

Reuters
·
Mar 05

Adaptive Biotechnologies CEO and Chairman Chad M. Robins Disposes of Common Shares

Reuters
·
Mar 04